Redx is a clinical-stage biotechnology company focused on the discovery and development of novel, small molecule, highly targeted therapeutics for the treatment of cancer and fibrotic disease.
| Non-Executive Director: |
Joseph Anderson, Natalie Berner |
| Non-Executive Chairman: |
Jane Griffiths |
| Chief Executive Officer : |
Lisa Anson |
| Independent Non-Executive Director: |
Bernhard Kirschbaum, Peter Presland, Rob Scott |
| Address: |
Block 33, Mereside, Alderley Park, United Kingdom |
| Phone: |
+44 (0)1625 469900 |
| Fax: |
|
| Website: |
http://redxpharma.com |
| Email: |
|